(Adnkronos) - “L’immunoterapia è l’arma che abbiamo nelle fasi più precoci del tumore alla mammella. È nostro dovere offrire ai pazienti questa opportunità nei centri specializzati di senologia dove ci sono professionisti dedicati alla cura di questo tumore”. Lo ha detto Andrea Botticelli, oncologo medico - coordinatore Breast Unit del Policlinico Umberto I, alla presentazione della campagna nazionale “Non sono tutti uguali. Tumori al seno e percorsi di vita”, promossa da Msd con la consulenza scientifica di Fondazione Aiom – Associazione italiana oncologia medica.
Category
🗞
NewsTranscript
00:00What is the need of precision medicine?
00:04When we prescribe a group of patients with the same characteristics,
00:08a treatment that is always the same, we will have extremely different responses.
00:12Some patients will respond very well, others for nothing.
00:15Some will be very bad for side effects and others will be fine.
00:19Here is the need, to understand which patient will respond and which will not respond,
00:23which will be fine and which will be bad.
00:25This is the need of precision medicine.
00:27This is what we have to do, choose the right medicine for the right patient,
00:31but above all at the right time.
00:33This is what we do in our clinics,
00:35because we personalize on the characteristics of the patient,
00:38on the age, on the characteristics of the medicines.
00:40We all know our medicines,
00:42but we must never forget that between the patient and the medicine
00:45there is the patient's metabolism, which is unique,
00:47and the pharmacological interactions.
00:49And then, of course, we personalize on the characteristics of the tumor.
00:52We look for those mutations, those switches that help us,
00:56that we can turn on or off with the drugs,
00:58and that help us and are part of the tumor cell.
01:01But today, above all, we can personalize on the immunological characteristics,
01:05because fortunately we have important weapons,
01:07our immune system.
01:09Immunotherapy is the weapon that we have in the earliest stages of the disease,
01:12for example in the triple negative disease, in the setting of the neodymium antenna.
01:15It is our duty to offer patients this opportunity.
01:18And how can we do this?
01:20But above all, where should we do it?
01:22In specialized centers,
01:23where there are professionals dedicated to the treatment of the breast tumor.
01:26This is where the centers of senology come into play,
01:28which will welcome the patient
01:30and with the dedicated professionals will follow her all the way.